Integra Lifesciences (IART) Receives a Sell from Morgan Stanley
Wood covers the Healthcare sector, focusing on stocks such as TransMedics Group, Becton Dickinson, and Zimmer Biomet Holdings. According to TipRanks, Wood has an average return of -0.5% and a 52.90% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Integra Lifesciences with a $14.60 average price target, which is a 22.69% upside from current levels. In a report released today, Citi also maintained a Sell rating on the stock with a $11.00 price target.
Wood covers the Healthcare sector, focusing on stocks such as TransMedics Group, Becton Dickinson, and Zimmer Biomet Holdings. According to TipRanks, Wood has an average return of -0.5% and a 52.90% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Integra Lifesciences with a $14.60 average price target, which is a 22.69% upside from current levels. In a report released today, Citi also maintained a Sell rating on the stock with a $11.00 price target.
